2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.Advanced Breast Cancer; ER-positive Breast Cancer; ESR1 Gene Mutation; HER2-negative Breast CancerRecruitingPhase 32026-08-24NCT06382948
Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS TrialNutritional and Metabolic Diseases, nutritional deficiency disease, nutritional disorderActive, not recruitingNot applicable2026-04-14NCT05257980